David Novack - Feb 3, 2024 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Role
President & COO
Signature
/s/ DAVID NOVACK
Stock symbol
DVAX
Transactions as of
Feb 3, 2024
Transactions value $
-$85,540
Form type
4
Date filed
2/6/2024, 04:45 PM
Previous filing
Jan 4, 2024
Next filing
Feb 13, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DVAX Common Stock Options Exercise +17.5K +398.72% 21.9K Feb 3, 2024 Direct F1, F2, F3
transaction DVAX Common Stock Tax liability -$85.5K -6.69K -30.55% $12.79 15.2K Feb 5, 2024 Direct F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DVAX Restricted Stock Unit Options Exercise -17.5K -100% 0 Feb 3, 2024 Common Stock 17.5K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Code M: Exercise or conversion of derivative security
F2 Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 3, 2021.
F3 Includes 1,202 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on August 15, 2023.
F4 Code F: Payment of exercise price or tax liability by delivering or withholding securities
F5 Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.